Merrimack Pharmaceuticals Inc (MACK) is near the top in its industry group according to InvestorsObserver. MACK gets an overall rating of 58. That means it scores higher than 58 percent of stocks. Merrimack Pharmaceuticals Inc gets a 75 rank in the Biotechnology industry. Biotechnology is number 49 out of 148 industries.
MACK has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on MACK!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 58 means the stock is more attractive than 58 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Merrimack Pharmaceuticals Inc Stock Today?
Merrimack Pharmaceuticals Inc (MACK) stock has risen 0.23% while the S&P 500 has fallen -0.24% as of 12:54 PM on Tuesday, Nov 21. MACK is up $0.03 from the previous closing price of $12.77 on volume of 19,075 shares. Over the past year the S&P 500 is higher by 14.84% while MACK is up 6.93%. MACK lost -$0.10 per share the over the last 12 months.
Click Here to get the full Stock Report for Merrimack Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
